Beranda › Leukemia Mielomonositik Juvenil › Michigan
Uji klinis Leukemia Mielomonositik Juvenil di Michigan
3 studi untuk Leukemia Mielomonositik Juvenil mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- C.S. Mott Children's Hospital, Ann Arbor
Menerima pesertaFase 1/2
1 Month – 21 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- C S Mott Children's Hospital, Ann Arbor
Menerima pesertaFase 1
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- dan 2 lainnya
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.